Information about Kluizen Pharma
My details
*
*
*

Kluizen Pharma (SRL)

Company information

Status
Active

Enterprise number

BE0501.612.041

VAT liability
Yes
Established
20-11-2012
Last balance sheet year
2025
Company size
Small 0 FTE
Principal activity
Activities of holding companies
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Kluizen Pharma

2025 2024 2023 2022
Profit/Loss 112,591 29 % 87,279 6 % 82,296 49 % 55,265
Equity 663,862 20 % 551,271 11 % 495,171 20 % 412,875
Gross margin 215,196 24 % 173,635 6 % 164,375 16 % 141,745

Publications from Kluizen Pharma

Date Publication
08-12-2023 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Resignations - Appointments - General meeting (NL)
07-05-2013 Capital - Shares (NL)
07-12-2012 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Kluizen Pharma?
The VAT number of Kluizen Pharma is BE 0501.612.041.
Wat is the PEPPOL ID of Kluizen Pharma?
The PEPPOL ID of Kluizen Pharma is 0208:0501612041. Log in or start a free trial to see the full overview.
When was Kluizen Pharma founded?
Kluizen Pharma was founded on 20-11-2012.
What is the address of Kluizen Pharma?
The current registered office of Kluizen Pharma is located at Jachthoorndreef 4, 9940 Evergem.
When was the last time Kluizen Pharma filed their annual financial statements?
The most recent financial statements of Kluizen Pharma were filed on 30-01-2026.
How many employees does Kluizen Pharma have?
There are currently no employees working at Kluizen Pharma or no workforce information is available.
What is the annual turnover of Kluizen Pharma?
At the time of its most recent financial statements, Kluizen Pharma did not publish any turnover figures. Kluizen Pharma reported a gross margin of €215,195.80.